Statera Biopharma
(OTC) STAB
Statera Biopharma Financials at a Glance
Market Cap
$7.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$3.69M
Net Income (TTM)
-$95.43M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-93.61 (Low)
Dividend
$0.00
Beta (Volatility)
-93.61 (Low)
Price
$0.00
Volume
1,450
Open
$0.00
Price
$0.00
Volume
1,450
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.03
Estimated Earnings Date
Feb 12, 2024
Dividend
$0.00
Beta (Volatility)
-93.61 (Low)
Price
$0.00
Volume
1,450
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.03
Estimated Earnings Date
Feb 12, 2024
STAB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Statera Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
16
CEO
Michael Kevin Handley, MBA
Website
www.staterabiopharma.comHeadquarters
Fort Collins, CO 80526, US
STAB Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
6677.48%
Return on Capital
-669.32%
Return on Assets
-823.86%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
71.42M
Volume
1.45K
Avg. Volume
4.56K
Financials (TTM)
Gross Profit
$2.59M
Operating Income
-$88.20M
EBITDA
-$19.83M
Operating Cash Flow
-$12.86M
Capital Expenditure
-$103.37K
Free Cash Flow
-$12.96M
Cash & ST Invst.
$506.10K
Total Debt
$7.41M
Statera Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$670.47K
+183.5%
Gross Profit
$501.12K
+315.5%
Gross Margin
74.74%
N/A
Market Cap
$7.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$154.35
N/A
Employees
46
N/A
Net Income
-$5.16M
+59.4%
EBITDA
-$1.35M
+85.7%
Quarterly Fundamentals
Total Cash
$506.10K
-94.6%
Total Debt
$7.41M
-55.7%
Accounts Receivable
$361.43K
+150.6%
Inventory
$105.64K
N/A
Long Term Debt
$686.14K
-95.0%
Short Term Debt
$6.72M
+118.1%
Return on Assets
-8.24%
N/A
Return on Invested Capital
-9.91%
N/A
Free Cash Flow
-$801.52K
+94.5%
Operating Cash Flow
-$801.52K
+94.5%